# Collegium Pharmaceutical, Inc (NASDAQ: COLL), Stoughton, MA – FDA Inspections

Source: https://www.keypedia.com/companies/collegium-pharmaceutical-inc/4b463c1e-27ef-417a-949c-588341578889

> Inspection records and compliance data for Collegium Pharmaceutical, Inc in Stoughton, Massachusetts. 3 FDA inspections on record, last inspected March 15, 2019. Publicly traded as NASDAQ: COLL.

---

## Details

- Name: Collegium Pharmaceutical, Inc
- FEI Number: 3005150234
- Address Line 1: 100 Technology Center Dr Ste 300
- City: Stoughton
- State: Massachusetts
- Zip Code: 02072
- Country Name: United States
- Address: 100 Technology Center Dr Ste 300, Stoughton, Massachusetts 02072, United States
- Country: United States

## Stock

- Stock ticker: COLL
- Exchange: NASDAQ
- Share price: $24.95
- Market cap: $775.3M
- Price as of: November 13, 2026

## Related Documents

- [FDA Inspection 1085723 - Collegium Pharmaceutical, Inc - 2019-03-15](https://www.keypedia.com/records/fda_inspections/collegium-pharmaceutical-inc/208d9a09-b4aa-455a-a4c1-a9c9e5b8aff0) — classification: No Action Indicated (NAI), source: FDA, date: March 15, 2019
- FDA Inspection 679887 - Collegium Pharmaceutical, Inc - 2010-08-31 — classification: No Action Indicated (NAI), source: FDA, date: August 31, 2010
- FDA Inspection 679887 - Collegium Pharmaceutical, Inc - 2010-08-31 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 31, 2010
- FDA Inspection 679887 - Collegium Pharmaceutical, Inc - 2010-08-31 — classification: No Action Indicated (NAI), source: FDA, date: August 31, 2010
- FDA Inspection 679887 - Collegium Pharmaceutical, Inc - 2010-08-31 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 31, 2010
- FDA Inspection 546655 - Collegium Pharmaceutical, Inc - 2008-10-23 — classification: No Action Indicated (NAI), source: FDA, date: October 23, 2008

## Related Companies

- [Parexel International Co.](https://www.keypedia.com/companies/parexel-international-co/3ffd0cd7-9a77-4371-8e06-ff14dbf9ae48)
- [Bioclinica, Inc.](https://www.keypedia.com/companies/bioclinica-inc/977908d6-8067-4569-b578-2121f0152c09)
- [GenPak Solutions LLC](https://www.keypedia.com/companies/genpak-solutions-llc/13198085-f8e3-47a5-abc8-bfc42ee9309e)
- [James A. Tumlin, MD](https://www.keypedia.com/companies/james-a-tumlin-md/a7d23105-ee14-42ab-9dac-83cf3a7039f1)
- [Watson Laboratories Inc](https://www.keypedia.com/companies/watson-laboratories-inc/884962cb-b3fb-4810-86cf-5d7ddac3b797)
- [Sigma-Aldrich Mfg LLC](https://www.keypedia.com/companies/sigma-aldrich-mfg-llc/68a7e154-16c3-472f-9df9-1e7fe0f1dd20)
- [University Of Mo At KC Hlth Science IRB](https://www.keypedia.com/companies/university-of-mo-at-kc-hlth-science-irb/ca433456-8d64-4bea-aa05-7d1a1f115241)
- [Thomas R.  Walters, MD, PI](https://www.keypedia.com/companies/thomas-r-walters-md-pi/0e61a94e-6cfb-42c1-8714-837259783f9d)
- [Shionogi Inc.](https://www.keypedia.com/companies/shionogi-inc/722eecd3-2e54-40aa-84f9-e38aa1d392aa)
- [Pablo E. Pergola, M.D., Ph.D.](https://www.keypedia.com/companies/pablo-e-pergola-md-phd/88ee6994-e22d-4e21-b605-cb56972bdffa)